✦ LIBER ✦

Model fusion: The next phase in developing animal models for parkinson’s disease

✍ Scribed by Amy B. Manning-BoĞ; J. William Langston

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 967 KB
Volume: 11
Category: Article
ISSN: 1029-8428
DOI: 10.1007/bf03033569

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A delivery strategy for rotenone microsp

A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease

✍ Jun Huang; Huaqing Liu; Wangwen Gu; Zhou Yan; Zhenghong Xu; Yongxin Yang; Xingzu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Neuroprotection by estrogen in animal mo

Neuroprotection by estrogen in animal models of ischemia and Parkinson's disease

✍ Istvan Merchenthaler; Paul J. Shughrue 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 686 KB

Neuroprotection of Pramipexole in UPS Im

Neuroprotection of Pramipexole in UPS Impairment Induced Animal Model of Parkinson’s Disease

✍ Chao Li; Yuan Guo; Wenjie Xie; Xingang Li; Joseph Janokovic; Weidong Le 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 682 KB

Role of glial cells in neurotoxin-induce

Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease

✍ Hironori Yokoyama; Hiroto Uchida; Hayato Kuroiwa; Jiro Kasahara; Tsutomu Araki 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 273 KB

Mucuna pruriens proves more effective th

Mucuna pruriens proves more effective than L-DOPA in Parkinson's disease animal model

✍ Ghazala Hussian; Bala V. Manyam 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Synergistic antidyskinetic effects of to

Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease

✍ Christopher Kobylecki; Michael P. Hill; Alan R. Crossman; Paula Ravenscroft 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 705 KB

## Abstract L‐Dopa‐induced dyskinesia in patients with Parkinson's disease can be alleviated by amantadine, an antagonist at __N__‐methyl‐D‐aspartate glutamate receptors. The antiepileptic drug topiramate, which blocks α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptors, has also been sh